Social Disability Lawyer Blog
Stay up to date with the latest news in the world of social disability law provided by the Los Angeles based Law Office of Irene Ruzin.
Hereditary Telangiectasia Disability Case SSDI Benefits
Genetic Telangiectasia (also known as Hereditary Hemorrhagic Telangiectasia, HHT, Osler-Weber-Rendu syndrome, and Osler-Weber-Rendu sickness) is a hereditary ailment in which the development of defective blood vessels increases. Excess blood vessels can develop in the skin, mucosal membranes, and even organs. The organs listed below are commonly affected:
i) Liver
Hereditary telangiectasia is characterised by a number of symptoms that can appear in a variety of combinations. The following are the most prevalent symptoms:
- Bleeding from the nose
- Bleeding in the digestive system
- Probable issues with the afflicted organ (s)
Hereditary telangiectasia treatments mainly focus on minimising bleeding, particularly internally. Surgery to remove faulty veins is frequently required. If a person with hereditary telangiectasia suffers from persistent bleeding, iron supplements and blood transfusions are frequently employed.
This generates improper connections between arteries and veins, known as arteriovenous malformations (AVMs). These AVMs can develop over time and bleed or burst, resulting in potentially fatal consequences.
The most prevalent symptom is spontaneous and unprovoked nosebleeds, which can occur on a regular basis. Persistent nose and intestinal bleeding can lead to severe iron deficiency anaemia and a low quality of life.
Hereditary hemorrhagic telangiectasia (HHT), also known as Osler-Weber-Rendu disease, is a genetic illness that you inherited.
Only around 20% of people with familial telangiectasia have internal lesions. Despite the fact that these lesions drain the body of iron and produce iron-deficient anaemia, they are commonly misdiagnosed. GI lesions are typically identified as a result of black stool or bloody vomiting.
The most dangerous symptom of the illness is arteriovenous malformation. These anomalies can occur in large organs or (in rare circumstances) in the spinal cord. The illness's effects and symptoms vary widely depending on which organs are affected. When the lungs are plagued by HHT, it produces shortness of breath or dyspnea.
Regardless of whose organ(s) are affected, the disorder causes much of a person's blood to skip the physiological organs entirely. This forces the heart to work harder, resulting in congestive heart failure. Swelling (especially in the legs), respiratory problems, and other organ-specific symptoms are also common.
X-rays, MRIs, and CAT Scans are used to detect the presence of ateriovenous malformations, which are generally surgically removed. These tests, together with physical examination, are also used to first identify the condition.
There is no known treatment for hereditary telangiectasia, nor is there a means to stop or decrease the progression of its symptoms. Treatment is restricted to dealing with symptoms as they arise. Aside from surgery, the major therapy is iron supplementation, either by iron pills, iron solutions, or IV iron sucrose. Blood transfusions are performed when anaemia becomes severe.
Section 7.07 of the Blue Book, the Social Security Administration's official list of potentially qualifying diseases, includes hereditary telangiectasia. To meet the listing criteria for Social Security disability compensation based on HHT, you must have experienced severe bleeding that prompted three or more blood transfusions in the five months before your disability claim's decision. More general information about blood disorders and anaemia may be found in Section 7.00. This information is also relevant for HHT disability claims.
Even if you do not qualify for disability payments as a direct result of your inherited telangiectasia, you may qualify because of the effects it has on the afflicted organs. Your claim can be assessed in reference to any and all main organs that have been impacted. If so, the specific conditions for qualifying for disability compensation can be found in the sections devoted to those organs.
Section 11.00 is most usually used for telangiectasia of the brain, Section 3.00 for telangiectasia of the lungs, Section 5.00 for telangiectasia of the liver, and Section 1.00 and/or 11.00 for telangiectasia of the spinal cord. If your telangiectasia affects other organs, the implications on those organs might be discussed in the Blue Book's individual sections.
You should include all medical paperwork while filing for disability compensation. This should specifically contain any medical imaging test findings. If your family has a genetic history, presenting it in your claim might be beneficial.
Your Disability Case Due to Hereditary Telangiectasia
Even under the best of circumstances, applying for Social Security disability payments can be difficult. It usually takes many months to acquire a decision. Applicants are originally refused disability payments 70% of the time. If you have hereditary telangiectasia, a rejection does not always indicate that you are ineligible for benefits; rather, the SSA requires further evidence of the condition's impact on your ability to undertake Substantial Gainful Activity (SGA).
The involvement of a Social Security disability attorney has been demonstrated to significantly increase applicants' odds of having their claims granted at all stages of the disability claims and appeals process. Fill out the accompanying request for a free assessment today to have an expert Social Security attorney at The Law Office of Irene Ruzin to review and advise you on your claim.
i) Liver
ii) Lungs
iii) Brain
Hereditary telangiectasia is characterised by a number of symptoms that can appear in a variety of combinations. The following are the most prevalent symptoms:
- Bleeding from the nose
- Bleeding in the digestive system
- Probable issues with the afflicted organ (s)
Hereditary telangiectasia treatments mainly focus on minimising bleeding, particularly internally. Surgery to remove faulty veins is frequently required. If a person with hereditary telangiectasia suffers from persistent bleeding, iron supplements and blood transfusions are frequently employed.
Telangiectasias are tiny vascular abnormalities that develop on the skin as well as in the mucous lining of the nose and gastrointestinal system. These lesions often bleed on and off. Nosebleeds are frequently the sole visible signs. Skin lesions, when present, tend to appear abruptly and are frequently induced by sun exposure. Lesions grow increasingly common as time passes.
The most prevalent symptom is spontaneous and unprovoked nosebleeds, which can occur on a regular basis. Persistent nose and intestinal bleeding can lead to severe iron deficiency anaemia and a low quality of life.
Hereditary hemorrhagic telangiectasia (HHT), also known as Osler-Weber-Rendu disease, is a genetic illness that you inherited.
Only around 20% of people with familial telangiectasia have internal lesions. Despite the fact that these lesions drain the body of iron and produce iron-deficient anaemia, they are commonly misdiagnosed. GI lesions are typically identified as a result of black stool or bloody vomiting.
The most dangerous symptom of the illness is arteriovenous malformation. These anomalies can occur in large organs or (in rare circumstances) in the spinal cord. The illness's effects and symptoms vary widely depending on which organs are affected. When the lungs are plagued by HHT, it produces shortness of breath or dyspnea.
Regardless of whose organ(s) are affected, the disorder causes much of a person's blood to skip the physiological organs entirely. This forces the heart to work harder, resulting in congestive heart failure. Swelling (especially in the legs), respiratory problems, and other organ-specific symptoms are also common.
X-rays, MRIs, and CAT Scans are used to detect the presence of ateriovenous malformations, which are generally surgically removed. These tests, together with physical examination, are also used to first identify the condition.
There is no known treatment for hereditary telangiectasia, nor is there a means to stop or decrease the progression of its symptoms. Treatment is restricted to dealing with symptoms as they arise. Aside from surgery, the major therapy is iron supplementation, either by iron pills, iron solutions, or IV iron sucrose. Blood transfusions are performed when anaemia becomes severe.
Section 7.07 of the Blue Book, the Social Security Administration's official list of potentially qualifying diseases, includes hereditary telangiectasia. To meet the listing criteria for Social Security disability compensation based on HHT, you must have experienced severe bleeding that prompted three or more blood transfusions in the five months before your disability claim's decision. More general information about blood disorders and anaemia may be found in Section 7.00. This information is also relevant for HHT disability claims.
Even if you do not qualify for disability payments as a direct result of your inherited telangiectasia, you may qualify because of the effects it has on the afflicted organs. Your claim can be assessed in reference to any and all main organs that have been impacted. If so, the specific conditions for qualifying for disability compensation can be found in the sections devoted to those organs.
Section 11.00 is most usually used for telangiectasia of the brain, Section 3.00 for telangiectasia of the lungs, Section 5.00 for telangiectasia of the liver, and Section 1.00 and/or 11.00 for telangiectasia of the spinal cord. If your telangiectasia affects other organs, the implications on those organs might be discussed in the Blue Book's individual sections.
You should include all medical paperwork while filing for disability compensation. This should specifically contain any medical imaging test findings. If your family has a genetic history, presenting it in your claim might be beneficial.
Your Disability Case Due to Hereditary Telangiectasia
Even under the best of circumstances, applying for Social Security disability payments can be difficult. It usually takes many months to acquire a decision. Applicants are originally refused disability payments 70% of the time. If you have hereditary telangiectasia, a rejection does not always indicate that you are ineligible for benefits; rather, the SSA requires further evidence of the condition's impact on your ability to undertake Substantial Gainful Activity (SGA).
The involvement of a Social Security disability attorney has been demonstrated to significantly increase applicants' odds of having their claims granted at all stages of the disability claims and appeals process. Fill out the accompanying request for a free assessment today to have an expert Social Security attorney at The Law Office of Irene Ruzin to review and advise you on your claim.
Stay Informed
When you subscribe to the blog, we will send you an e-mail when there are new updates on the site so you wouldn't miss them.
Comments